Youth Sentinel is a youth-led publication exploring medicine, ethics, public health, and the social consequences of scientific progress — with clarity, rigor, and editorial discipline.
The story of Lulu and Nana still shapes the debate over whether scientists should make heritable edits before the long-term risks are understood.
A series on silence, communication, trust, and power in clinical care.
Essays on illness, uncertainty, physician identity, and the human side of medicine.
Historical and global perspectives on health systems, equity, and reform.
A breakthrough gene therapy may have cured one baby, but the larger question is who gets left out when innovation is priced like a luxury.
A student perspective on public trust, vaccine policy, and the long-term risks of treating a proven protection as optional.
A first-person argument for broader international health coverage and why underreported disease outbreaks still matter to American readers.
Reporting on medicine, clinical care, treatment access, and the human consequences of scientific progress.
Reporting on health systems, prevention, epidemiology, and the institutions that shape public well-being.
A section for medical ethics, scientific responsibility, consent, and the moral questions that travel with innovation.
Research covers discoveries across science and technology, with attention to why they matter for human life, medicine, public health, ethics, and society.
Essays are Youth Sentinel’s home for reflective, evidence-based writing on medicine, ethics, public health, and the human consequences of scientific progress.
Browse essaysWe welcome students interested in careful science writing, public health analysis, medical humanities, and interviews with experts.
Why personality labels, brain myths, and neat identity boxes remain appealing even when they flatten who people really are.
The story of Lulu and Nana still shapes the debate over whether scientists should make heritable edits before the long-term risks are understood.
A breakthrough gene therapy may have cured one baby, but the larger question is who gets left out when innovation is priced like a luxury.
A student perspective on public trust, vaccine policy, and the long-term risks of treating a proven protection as optional.
A first-person argument for broader international health coverage and why underreported disease outbreaks still matter to American readers.
